IGF-1 LR3 1mg (Long Arg3)

Comprehensive Laboratory Profile

The acquisition of stable, long-acting growth factors is a critical requirement for institutional laboratories conducting advanced tissue engineering, cellular regeneration, and metabolic research. By integrating the IGF-LR3 1mg peptide into your specialized cell culture protocols, your facility secures a highly purified, synthetically engineered growth factor analog designed specifically for prolonged in-vitro activity.

Synthesized entirely within the USA to the most rigorous industry standards, this specialized compound delivers the analytical precision required by modern research facilities. Utilizing the IGF-LR3 1mg peptide ensures that your laboratory acquires definitive, reproducible data free from the rapid degradation typically associated with endogenous growth factor analogs.

Biochemical Profile: The Long Arg3 Modification

Endogenous Insulin-like Growth Factor-1 (IGF-1) is a 70-amino acid polypeptide essential for cellular growth. However, in physiological and simulated serum environments, native IGF-1 is rapidly neutralized by Insulin-like Growth Factor Binding Proteins (IGFBPs).

The IGF-LR3 1mg analog overcomes this limitation through profound structural engineering. It features an 83-amino acid sequence that includes a critical substitution at the third position—replacing Glutamic Acid with Arginine (Arg3)—alongside a 13-amino acid extension at the N-terminus. This specific molecular modification drastically reduces the peptide’s binding affinity for IGFBPs by over 95%. Consequently, the active half-life of the peptide is extended from roughly 20 minutes to over 20 hours, making it an exceptionally powerful tool for sustained cellular signaling.

Mechanism of Action in Cellular Assays

When researchers introduce the IGF-LR3 1mg compound into an isolated cell culture, the unbound peptide is free to continuously interact with the Type 1 IGF Receptor (IGF-1R). The binding of this analog initiates a potent intracellular signaling cascade, primarily activating the PI3K/AKT and MAPK pathways.

This sustained activation results in profound cellular changes. Unlike compounds that strictly promote cellular hypertrophy (an increase in the size of existing cells), the sustained signaling of the IGF-LR3 1mg formulation uniquely stimulates cellular hyperplasia (an increase in the number of new cells). This aggressive promotion of cellular division and the simultaneous inhibition of apoptosis makes it a foundational compound in skeletal muscle, epithelial, and neuronal tissue modeling.

Primary In-Vitro Research Applications

The unprecedented stability and potency of this engineered analog make it a cornerstone for complex regenerative and metabolic studies. Current scientific literature utilizes the IGF-LR3 1mg peptide primarily for:

• Cellular Hyperplasia Modeling: Documenting the kinetic rate of cell division and replication in isolated myoblast or fibroblast cultures.

• Tissue Engineering & Scaffold Seeding: Evaluating the survival and proliferation rates of cells seeded onto artificial extracellular matrices.

• PI3K/AKT Pathway Mapping: Utilizing the sustained half-life to study long-term intracellular signaling without the need for constant, disruptive re-administration.

• Metabolic Substrate Uptake Assays: Measuring the peptide’s ability to facilitate rapid amino acid and glucose transport across the cellular membrane.

Absolute Purity and Quality Assurance

At Ion Peptides, we strictly recognize that anomalous data caused by degraded or structurally compromised growth factors will critically compromise months of dedicated research and funding. Therefore, every single batch of our IGF-LR3 1mg peptide is subjected to uncompromising third-party analytical testing.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. This absolute precision ensures the complete isolation of the 83-amino acid sequence from residual synthesis solvents or truncated protein fragments. Furthermore, rigorous Mass Spectrometry (MS) is employed to verify the precise molecular weight. By securing your IGF-LR3 1mg supply through our secure USA synthesis network, you guarantee your facility receives materials that meet the highest echelons of analytical compliance.

Lyophilization, Storage, and Reconstitution Protocols

To ensure maximum molecular stability during secure domestic transit, the IGF-LR3 1mg vial is supplied as a lyophilized (freeze-dried) solid powder. Strict handling protocols must be observed to maintain the integrity of this delicate protein upon arrival.

Prior to reconstitution, the lyophilized vial must be stored in a climate-controlled, dark environment, ideally at or below -20°C. When your laboratory is prepared to initiate assay testing, the reconstitution process requires careful attention to the chemical micro-environment.

1. Allow the vial to slowly reach ambient room temperature to prevent condensation.

2. Introduce a sterile diluent slowly, directing the fluid flow down the inner wall of the glass to prevent sheer stress on the fragile peptide structure. (Note: While bacteriostatic water is standard, many advanced laboratory protocols utilize a dilute acetic acid solution, such as 10mM to 100mM, to ensure complete dissolution and long-term stability of the LR3 analog).

3. Do not agitate, shake, or vortex the vial. Allow the IGF-LR3 1mg compound to dissolve naturally into a clear solution via gentle, rotational swirling.

4. Once reconstituted, immediately refrigerate the solution at 2°C to 8°C and utilize within standard laboratory protocol timelines.